Here's Why You Should Avoid Investing in Danaher Stock Right Now

Zacks12-10

Danaher Corporation DHR has failed to impress investors with its recent operational performance due to softness in the Life Sciences segment. Also, increasing expenses are likely to impede the company...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2490454880?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/.0d4ti2DGVi3bNYp._AqWQ--~B/aD00MTg7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/311f8faad3dc8bd40db7490fb5f90c54","is_english":true,"pubTime":"2024-12-10 23:12","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2490454880","market":"us","top_or_hot":-1,"title":"Here's Why You Should Avoid Investing in Danaher Stock Right Now","media":"Zacks","content":"<div>\n<p>Danaher Corporation DHR has failed to impress investors with its recent operational performance due to softness in the Life Sciences segment. Also, increasing expenses are likely to impede the company...</p>\n\n<a href=\"https://finance.yahoo.com/news/heres-why-avoid-investing-danaher-151200064.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why You Should Avoid Investing in Danaher Stock Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why You Should Avoid Investing in Danaher Stock Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-10 23:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/heres-why-avoid-investing-danaher-151200064.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Danaher Corporation DHR has failed to impress investors with its recent operational performance due to softness in the Life Sciences segment. Also, increasing expenses are likely to impede the company...</p>\n\n<a href=\"https://finance.yahoo.com/news/heres-why-avoid-investing-danaher-151200064.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0820561818.USD","symbol_name":"安联收益及增长平衡基金Cl AM DIS","start_time":0,"source_url":"https://finance.yahoo.com/news/heres-why-avoid-investing-danaher-151200064.html","article_id":"2490454880","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/.0d4ti2DGVi3bNYp._AqWQ--~B/aD00MTg7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/311f8faad3dc8bd40db7490fb5f90c54"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2490454880","pubTimestamp":1733843520,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Danaher Corporation DHR has failed to impress investors with its recent operational performance due to softness in the Life Sciences segment. Also, increasing expenses are likely to impede the company’s earnings in the quarters ahead.Danaher is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. It is headquartered in Washington, DC.DHR currently carries a Zacks Rank #4 . In the past year, the stock has gained 6.6% against the industry’s 6.5% decline.Better-ranked companies are discussed below.Federal Signal Corporation FSS presently carries a Zacks Rank #2 . You can see the complete list of today’s Zacks #1 Rank  stocks here.FSS delivered a trailing four-quarter average earnings surprise of 11.8%. In the past 60 days, the Zacks Consensus Estimate for Federal Signal’s 2024 earnings has increased 3.1%.Zurn Elkay Water Solutions Corporation ZWS presently carries a Zacks Rank of 2. The company delivered ","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","LU0708995401.HKD":"FRANKLIN U.S. OPPORTUNITIES \"A\" (HKD) ACC","LU2125909593.SGD":"Natixis Thematics Meta R/A SGD","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","SG9999001176.USD":"United Global Healthcare Acc USD","FSS":"联邦信号","LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU1917777945.USD":"安联专题基金Cl AT Acc","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","ZWS":"Zurn Water Solutions","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU1923622614.USD":"Natixis Thematics Meta R/A USD","RBC":"RBC轴承","BK4149":"建筑机械与重型卡车","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","IE0004445239.USD":"JANUS HENDERSON US FORTY \"A2\" (USD) ACC","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU0312595415.SGD":"Schroder ISF Global Climate Change Equity A Acc SGD","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","LU0390134368.USD":"FRANKLIN GLOBAL GROWTH \"A\" (USD) ACC","BK4588":"碎股","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU0107464264.USD":"abrdn SICAV I - GLOBAL INNOVATION EQUITY \"A\" (USD) ACC","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","LU2125910179.SGD":"Natixis Thematics Water H-R/A SGD","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","BK4086":"建筑产品","LU2063271972.USD":"富兰克林创新领域基金","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","BK4504":"桥水持仓","LU0511384066.AUD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (AUDHDG) ACC","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","LU0289960550.SGD":"AB FCP I - GLOBAL EQUITY BLEND PORTFOLIO 'A' (SGD) ACC","DHR":"丹纳赫","IE00B64QTZ34.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) ACC","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU0289961442.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"AX\" (SGD) ACC","LU0672654240.SGD":"FTIF - Franklin US Opportunities A Acc SGD-H1"},"translate_title":"这就是为什么您现在应该避免投资丹纳赫股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZWS":1,"DHR":1,"FSS":1,"RBC":1},"content_text":"Danaher Corporation DHR has failed to impress investors with its recent operational performance due to softness in the Life Sciences segment. Also, increasing expenses are likely to impede the company’s earnings in the quarters ahead.Danaher is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. It is headquartered in Washington, DC.DHR currently carries a Zacks Rank #4 (Sell). In the past year, the stock has gained 6.6% against the industry’s 6.5% decline.\nImage Source: Zacks Investment Research\nLet’s discuss the factors, which are likely to continue taking a toll on this company.Segment Weakness: Weakness in Danaher’s Instrument businesses, led by lower demand across pharma and biotech markets in China, has been weighing on the Life Sciences segment. The company has been witnessing a sales decline in mass spectrometry, flow cytometry & lab automation solutions and microscopy businesses due to soft demand for equipment in major end markets. Softness in the genomics consumables business, owing to tepid sales in the gene reading and proteins product lines, remains concerning for the segment.Also, weakness in the Biotechnology segment raises concerns for the company. Decreased demand in the discovery and medical business has been weighing on the performance of the Biotechnology segment.Increasing Expenses: Danaher has been dealing with the adverse impacts of high costs and expenses. The company’s selling, general and administrative (SG&A) expenses increased 19.2% year over year in the third quarter of 2024 due to the impact of the Abcam acquisition, including the associated amortization expense. The metric, as a percentage of net sales, increased 480 basis points to 35.5% in the quarter. Also, it's worth noting that in 2023, its SG&A expenses, as a percentage of net sales, increased 400 basis points to 30.7%.Forex Woes: Danaher has operations in multiple nations. Such business diversifications expose it to risks stemming from unfavorable movements in foreign currencies, geopolitical issues and other headwinds. Forex woes had an adverse impact of 1% on the company’s revenue growth in the first nine months of 2024.\nStocks to Consider\nBetter-ranked companies are discussed below.Federal Signal Corporation FSS presently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.FSS delivered a trailing four-quarter average earnings surprise of 11.8%. In the past 60 days, the Zacks Consensus Estimate for Federal Signal’s 2024 earnings has increased 3.1%.Zurn Elkay Water Solutions Corporation ZWS presently carries a Zacks Rank of 2. The company delivered a trailing four-quarter average earnings surprise of 8.5%.In the past 60 days, the Zacks Consensus Estimate for ZWS’ 2024 earnings has increased 2.5%.RBC Bearings Incorporated RBC presently carries a Zacks Rank of 2. The company delivered a trailing four-quarter average earnings surprise of 2.5%.In the past 60 days, the consensus estimate for RBC’s fiscal 2025 earnings has increased 0.5%.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nDanaher Corporation (DHR) : Free Stock Analysis Report\nRBC Bearings Incorporated (RBC) : Free Stock Analysis Report\nFederal Signal Corporation (FSS) : Free Stock Analysis Report\nZurn Elkay Water Solutions Cor (ZWS) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2490454880"}